Home
>
National Drug Code (NDC)
>
ARANESP
ARANESP - 55513-027-04 - (darbepoetin alfa)
Drug Information of ARANESP
| Product NDC: | 55513-027 |
| Proprietary Name: | ARANESP |
| Non Proprietary Name: | darbepoetin alfa |
| Active Ingredient(s): | 150 ug/.3mL & nbsp; darbepoetin alfa |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ARANESP
| Product NDC: | 55513-027 |
| Labeler Name: | Amgen Inc |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103951 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20060911 |
Package Information of ARANESP
| Package NDC: | 55513-027-04 |
| Package Description: | 1 BLISTER PACK in 1 PACKAGE (55513-027-04) > 4 SYRINGE in 1 BLISTER PACK > .3 mL in 1 SYRINGE (55513-027-01) |
NDC Information of ARANESP
| NDC Code | 55513-027-04 |
| Proprietary Name | ARANESP |
| Package Description | 1 BLISTER PACK in 1 PACKAGE (55513-027-04) > 4 SYRINGE in 1 BLISTER PACK > .3 mL in 1 SYRINGE (55513-027-01) |
| Product NDC | 55513-027 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | darbepoetin alfa |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20060911 |
| Marketing Category Name | BLA |
| Labeler Name | Amgen Inc |
| Substance Name | DARBEPOETIN ALFA |
| Strength Number | 150 |
| Strength Unit | ug/.3mL |
| Pharmaceutical Classes | Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE] |
